ClinicalTrials.gg
CompletedNCT05912504Updated Mar 5, 2026

Long Term Follow-up of Vertebral Compression Fracture In-patients Treated: A Retrospective Chart Review and Survey

An observational study in Vertebral Compression Fracture, Korean Traditional Medicine and Integrative Korean Medicine, sponsored by Jaseng Medical Foundation. Completed at 1 site in South Korea. Open to participants aged 19 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-05.

Sponsored by Jaseng Medical Foundation · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
70
Ages
19 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to reveal the effectiveness and safety of integrative Korean medicine for Vertebral Compression Fracture in-patients by observing inpatients treated with integrative Korean medicine.

This study is a retrospective observational study. The subjects for study are patients diagnosed with Vertebral Compression Fracture and who have been admitted to four Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, and Haeundae) for 2016.04.01-2022.06.30.

Medical records of selected patients will be analyzed, and telephone surveys will be conducted for each patient. The survey questions are Numeric ratinc scale (NRS), Oswestry Disability Index(ODI), quality of life, and Patient Global Impression of Change (PGIC), etc.

02

Conditions studied

  • Vertebral Compression Fracture
  • Korean Traditional Medicine
  • Integrative Korean Medicine
  • Vertebral Compression

Browse trials for

Keywords

  • Compression Fracture
  • Integrated Complementary and Alternative Medicine:
03

In context

Fractures, Compression

50 studies on the registry are indexed under Fractures, Compression; 10 are open to participants now.

This study's enrollment of 70 is below the median of 100 across 16 observational studies indexed under Fractures, Compression.

Browse Fractures, Compression studies →

Lead sponsor

Jaseng Medical Foundation is the lead sponsor of 69 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 80 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Recruit people who meet the selection criteria and conduct a telephone survey.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients diagnosed with Acute Compression Fracture' of thoracic or lumbar vertebrae from EMR X-ray or MRI, CT imaging (The temporal criterion for dividing acute and chronic compression fractures was based on 3 months after symptoms began in the case of compression fractures caused by osteoporosis, and acute and chronic were also divided based on 3 months after trauma.)
  2. Patient hospitalized for more than a week
  3. Pateints above 19 years old and below 80 years old
  4. Patients who have agreed to participate the study

Exclusion criteria

Exclusion Criteria:

  1. Where the vertebral fracture is not a vertebral body, but a transverse protrusion, a polar protrusion, etc.
  2. Other chronic conditions that may interfere with the interpretation of treatment effects or outcomes: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  3. If the cause of pain is due to soft tissue disease, not the spine: tumor, fibromyalgia, rheumatoid arthritis, gout, etc.
  4. a person with a congenital spinal disorder
  5. For patients within 3 months of spinal surgery
  6. A person who is unable to communicate normally due to dementia or mild cognitive impairment;
  7. Other cases where the researcher is not suitable for participation in the study.
  8. Those who do not agree to participate in the study.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
70 participants (actual)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • OtherPhoen survey

    A questionnaire about the current symptoms and satisfaction for received treatment will be conducted over the phone for patients.

06

What researchers measure

Primary outcomes

  1. Numeric rating scale (NRS)

    NRS uses an 11-point scale to evaluate current neck pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'. NRS was assessed at admission, 2 weeks after admission, discharge, and long term follow up.

    Time frame: [Time Frame: Finish survey by November 2023]

Secondary outcomes

  1. Oswestry Disability Index(ODI)

    ODI is a 10-item questionnaire developed to evaluate the degree of disability for lower back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. The investigators will conduct an validated Korean NDI questionnaire

    Time frame: [Time Frame: Finish survey by November 2023]

  2. The five level version of EuroQol-5 Dimension (EQ-5D)

    EQ-5D is most widely used as a method of indirectly calculating the quality of life from various aspects. The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about) In this study, the validated Korean version questionnaire will be used.

    Time frame: [Time Frame: Finish survey by November 2023]

  3. Patient Global Impression of Change (PGIC)

    PGIC is an indicator that evaluates the improvement of patients in 7 steps, and the subject responds with improvement of functional limitation after treatment with 7 likert. (1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse).

    Time frame: [Time Frame: Finish survey by November 2023]

  4. Spine Operation

    Operation status

    Time frame: [Time Frame: Finish survey by November 2023]

  5. Treatment after discharge survey

    Treatment history after discharge

    Time frame: [Time Frame: Finish survey by November 2023]

  6. Satisfaction with integrative Korean medicine survey

    Preference for integrative Korean medicine, satisfaction with integrative Korean medicine, How helpful hospitalization has been for returning to work and adjusting to daily life.

    Time frame: [Time Frame: Finish survey by November 2023]

07

Study locations

1 site
  • Bucheon Jaseng Hospital of Korean Medicine
    Bucheon-si, Gyeonggi Province 14598, South Korea
08

References and documents

Publications

  • Sim HA, Jung W, Kim SD, Park H, Lee J, Jo H, Lee Y, Heo I, Seo BK, Shin WC, Cho JH, Lee YJ, Kim D, Ha IH. Long-term follow-up of vertebral compression fractures in inpatients treated with integrative Korean medicine: An observational study. Medicine (Baltimore). 2026 Jan 9;105(2):e46883. doi: 10.1097/MD.0000000000046883. PubMed 41517687 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2023 to primary completion in Feb 2024, 13 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2023
First posted
Jun 22, 2023
StartActual
Jan 20, 2023
Primary completionActual
Feb 20, 2024
CompletionActual
Feb 20, 2024
Last update
Mar 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05912504
Lead sponsor
Jaseng Medical Foundation
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Jun 22, 2023
Start date
Jan 20, 2023
Primary completion
Feb 20, 2024
Completion
Feb 20, 2024
Last update
Mar 5, 2026

Study contacts

In-Hyuk Ha, Dr
study chair · Bucheon Jaseng Hospital of Korean Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion